ATRT Publications

Just Added

Published 27 February 2020

Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333

Published 31 December 2019

Molecular subgrouping of Atypical Teratoid / Rhabdoid Tumors (ATRT) – a reinvestigation and current consensus

Older Publications

   1. Human Pluripotent Stem Cell-Derived Tumor Model Uncovers the Embryonic Stem Cell Signature as a Key Driver in 

        Atypical Teratoid/Rhabdoid Tumor.

   2. Role of early and aggressive post-operative radiation therapy in improving outcome for pediatric central nervous 

        system atypical teratoid/rhabdoid tumor.

   3. A Phase 2 Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children’s Oncology

        Group Phase 1 and Pilot Consortium (ADVL0921) .

   4. Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central

        nervous system tumors.

   5. Survival Benefit with Gross Total Resection and Adjuvant Radiotherapy in Childhood Atypical Teratoid/Rhabdoid

        Tumors: Results of a Single-Center Cohort of 27 Cases.

   6. Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies.

   7. Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for

        SWI/SNF and Polycomb in Gene Regulation.

   8. Overall Survival of Primary Intracranial Atypical Teratoid Rhabdoid Tumor Following Multimodal Treatment: A Pooled

        Analysis of Individual Patient Data.

   9. Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical

        Teratoid/Rhabdoid Tumors.

 

10. Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group.

 

11. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic

        progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid

        tumors: the Head Start III experience.

 

12. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry.

 

13. Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor.

14. Atypical teratoid rhabdoid tumor: current therapy and future directions.

15. Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase

        pathway as a therapeutic target.

16. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed

        radiotherapy.

17. Atypical Teratoid Rhabdoid Tumors

18. MEK/MELK inhibition and blood-brain barrier-deficiencies in atypical teratoid/rhabdoid tumors

Hope4ATRT Foundation

is a research entity of

Out of Zion, Inc.

Mailing Address: 

P.O. Box 6130   New York, NY  10150